ArticleHealth science reports2025
Predictive Factors Associated With Multidrug-Resistant Tuberculosis Among Tuberculosis Patients in Southwest Ethiopia: An Unmatched Case-Control Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multidrug-resistant tuberculosis (MDR-TB) presents a significant public health challenge, particularly in resource-limited settings like Ethiopia. Identifying factors associated with MDR-TB is essential for designing effective control strategies. The objective of this study was to identify the determinants of multidrug-resistant tuberculosis (MDR-TB) in southwest Ethiopia, to inform targeted public health interventions, improve prevention and control strategies, and support evidence-based planning in regions with limited resources and a high burden of drug-resistant TB. Methods: An unmatched case-control study was conducted from October 2022 to February 2023 in Jimma and Illubabor zones, located in Southwest Ethiopia. A total of 201 participants were initially selected, of whom 200 (66 MDR-TB cases and 134 drug-susceptible TB controls) completed the study and were included in the final analysis. Data were collected through interviewer-administered questionnaires and review of medical records. Variables with a Results: Among the 200 participants included, several factors were significantly associated with MDR-TB. Compared to those aged 15-24 years, participants aged 25-34 years (AOR = 3.8, 95% CI: 1.34-8.36) and 35-44 years (AOR = 3.3, 95% CI: 1.42-7.65) had higher odds of MDR-TB. Other significant predictors included urban residence (AOR = 2.1), contact with TB or known MDR-TB patients (AOR = 2.21), HIV infection (AOR = 1.9), substance use (alcohol, khat, illicit drugs), psychological illness (AOR = 9.4), previous TB treatment (AOR = 5.3), retreatment history (AOR = 13.9), low BMI (< 18.5 kg/m²; AOR = 3.9), living more than 25 km from treatment centers (AOR = 6.2), and perceived social stigma (AOR = 5.2). Conclusion: This study identified multiple independent predictors of MDR-TB, including previous TB treatment, retreatment history, substance use, HIV infection, psychological illness, malnutrition, and limited access to healthcare. Sociodemographic factors such as age, urban residence, and perceived stigma were also significant. These findings highlight the need for integrated TB control strategies addressing clinical management, behavioral and psychosocial support, and improved healthcare access to effectively reduce MDR-TB in Southwest Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.